<! DOCTYPE = html>
<html>
<title>CS657 - Prescription</title>
<style>
div.container {
		width: 100%;
		border: 1px solid gray;
}

header{
		padding: 0.5em;
		#color: black;
		background-color: orange;
		clear: left;
		text-align: center;
}
.footer{
		padding : 1em;
		background-color: orange;
		text-align: center;
		<!--- position: fixed;>
		bottom : 0;
		width : 100%;
}

nav {
		float: left;
		max-width: 160px;
		margin: 0;
		padding: 1em;
}

nav ul {
		list-style-type: none;
		padding: 0;
}
	 
nav ul a {
		text-decoration: none;
}

article {
		margin-left: 170px;
		border-left: 1px solid gray;
		padding: 1em;
		overflow: hidden;
}
table {
		font-family: arial, sans-serif;
		border-collapse: collapse;
		width: 80%;
}

td, th {
		border: 4px solid #000000;
		text-align: middle;
		padding: 8px;
}

tr:nth-child(even) {
		background-color: #eeeeee;
}	

div.box {
		background-color: white;
		width: 300px;
		border: 2px solid green;
		padding: 10px;
		margin: 25px;
}
</style>
<body>
<div class="container">
	<header><h1>
		IIT Kanpur Medical Labs</h1>
	</header>
	<hr>	<h2> Precription for the query: </h2>
	<div class="box">
	memory loss, confusion, depression
	</div>
	<hr>	<h2>
		Identified Disease: </h2>
	<div class="box">
	Delirium
	</div>
	<hr>	<h2>More Symptoms: </h2>
	<div class="box">
	Ataxia, Akathisia, Spasm, Headache, Quadriplegia
	</div>
		<hr><h2>
Medication:</h2>
<table>
	<tr>
		<th>Serial No</th>
		<th>Drug Name</th>
		<th>Group</th>
		<th>Indication</th>
	</tr>	<tr>
		<td>1.</td>
		<td>Amitriptyline</td>
		<td>Approved</td>
		<td>Indicated for the treatment of major depressive disorder in adultsIndicated for the management of neuropathic pain in adultsIndicated for the prophylactic treatment of chronic tension type headache (CTTH) in adultsIndicated for the prophylactic treatment of migraine in adultsIndicated for the the treatment of nocturnal enuresis in children aged 6 years and above when organic pathology, including spina bifida and related disorders, have been excluded and no response has been achieved to all other non-drug and drug treatments, including antispasmodics and vasopressin-related products. This medicinal product should only be prescribed by a healthcare professional with expertise in the management of persistent enuresis.-Other off-label uses include irritable bowel syndrome, sleep disorders, diabetic neuropathy, agitation and insomnia</td>
	</tr>	<tr>
		<td>2.</td>
		<td>Sertraline</td>
		<td>Approved</td>
		<td>For the management of major depressive disorder (MDD), posttraumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), panic disorder (PD) with or without agoraphobia, premenstrual dysphoric disorder (PMDD), and social anxiety disorder (SAD) [FDA Label]. It may be used for premature ejaculation and vascular headaches as off-label indications. </td>
	</tr>	<tr>
		<td>3.</td>
		<td>Colchicine</td>
		<td>Approved</td>
		<td>For treatment and relief of pain in attacks of acute gouty arthritis.</td>
	</tr>	<tr>
		<td>4.</td>
		<td>Haloperidol</td>
		<td>Approved</td>
		<td>For the treatment of schizophrenia [10]For the treatment of acute psychosis in acutely agitated schizophrenic patients with moderately severe to very severe symptoms [10]For the treatment of severe behavioral or psychological symptoms of dementia [10]For the treatment of delirium in the pediatric intensive care unit [10]For the treatment of agitation or delirium [10]For agitation† or delirium in adult patients with no underlying psychiatric illness [10]For use as a second-line agent for rescue treatment of chemotherapy-induced nausea/vomiting [10]For the treatment of irritability associated with autistic disorder [10]For the treatment of tics and vocal utterances associated with Tourette's syndrome [10]For the treatment of severe behavioral problems associated with oppositional defiant disorder or other disruptive behavioral disorders, or for the treatment of attention-deficit hyperactivity disorder (ADHD) in pediatric patients who show excessive motor activity with accompanying conduct disorders [10]</td>
	</tr>	<tr>
		<td>5.</td>
		<td>Nortriptyline</td>
		<td>Approved</td>
		<td>Primarily indicated for the relief of symptoms of depression.</td>
	</tr>	<tr>
		<td>6.</td>
		<td>Protriptyline</td>
		<td>Approved</td>
		<td>For the treatment of depression. </td>
	</tr>	<tr>
		<td>7.</td>
		<td>Amantadine</td>
		<td>Approved</td>
		<td>For the chemoprophylaxis, prophylaxis, and treatment of signs and symptoms of infection caused by various strains of influenza A virus. Also for the treatment of parkinsonism and drug-induced extrapyramidal reactions.</td>
	</tr>	<tr>
		<td>8.</td>
		<td>Benzatropine</td>
		<td>Approved</td>
		<td>For use as an adjunct in the therapy of all forms of parkinsonism and also for use in the control of extrapyramidal disorders due to neuroleptic drugs.</td>
	</tr>	<tr>
		<td>9.</td>
		<td>Idarucizumab</td>
		<td>Approved</td>
		<td>For use in patients treated with Dabigatran when reversal of the anticoagulant effects of dabigatran is needed for emergency surgery/urgent procedures and in life-threatening or uncontrolled bleeding.</td>
	</tr>	<tr>
		<td>10.</td>
		<td>Ergoloid mesylate</td>
		<td>Approved</td>
		<td>For use as an adjunct therapy for patients with dementia.</td>
	</tr>	<tr>
		<td>11.</td>
		<td>Metixene</td>
		<td>Approved</td>
		<td>Used for the symptomatic treatment of parkinsonism.</td>
	</tr>	<tr>
		<td>12.</td>
		<td>Angiotensin II</td>
		<td>Approved, Investigational</td>
		<td>Angiotensin II is a vasoconstrictor indicated for increasing blood pressure in adults with septic or other distributive shock [FDA Label].</td>
	</tr>	<tr>
		<td>13.</td>
		<td>Desipramine</td>
		<td>Approved, Investigational</td>
		<td>For relief of symptoms in various depressive syndromes, especially endogenous depression. It has also been used to manage chronic peripheral neuropathic pain, as a second line agent for the management of anxiety disorders (e.g. panic disorder, generalized anxiety disorder), and as a second or third line agent in the ADHD management. </td>
	</tr>	<tr>
		<td>14.</td>
		<td>Methylphenidate</td>
		<td>Approved, Investigational</td>
		<td>For use as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity.</td>
	</tr>	<tr>
		<td>15.</td>
		<td>Dexmethylphenidate</td>
		<td>Approved, Investigational</td>
		<td>Dexmethylphenidate is used as a treatment for ADHD, ideally in conjunction with psychological, educational, behavioral or other forms of treatment.</td>
	</tr>	<tr>
		<td>16.</td>
		<td>Biperiden</td>
		<td>Approved, Investigational</td>
		<td>For use as an adjunct in the therapy of all forms of parkinsonism and control of extrapyramidal disorders secondary to neuroleptic drug therapy.</td>
	</tr>	<tr>
		<td>17.</td>
		<td>Benzodiazepine</td>
		<td>Approved, Investigational</td>
		<td>Not Available</td>
	</tr>	<tr>
		<td>18.</td>
		<td>Thiamine</td>
		<td>Approved, Investigational, Nutraceutical, Vet approved</td>
		<td>For the treatment of thiamine and niacin deficiency states, Korsakov's alcoholic psychosis, Wernicke-Korsakov syndrome, delirium, and peripheral neuritis.</td>
	</tr>	<tr>
		<td>19.</td>
		<td>Clomipramine</td>
		<td>Approved, Investigational, Vet approved</td>
		<td>May be used to treat obsessive-compulsive disorder and disorders with an obsessive-compulsive component (e.g. depression, schizophrenia, Tourette’s disorder).Unlabeled indications include: depression, panic disorder, chronic pain (e.g. central pain, idiopathic pain disorder, tension headache, diabetic peripheral neuropathy, neuropathic pain), cataplexy and associated narcolepsy (limited evidence), autistic disorder (limited evidence), trichotillomania (limited evidence), onchophagia (limited evidence), stuttering (limited evidence), premature ejaculation, and premenstrual syndrome. </td>
	</tr>	<tr>
		<td>20.</td>
		<td>Phentermine</td>
		<td>Approved, Illicit</td>
		<td>For the treatment and management of obesity.</td>
	</tr>	<tr>
		<td>21.</td>
		<td>Picrotoxin</td>
		<td>Experimental</td>
		<td>Used internally for relieving respiratory distress. Also for use as an antidote in poisoning by CNS depressants, especially barbiturates.</td>
	</tr>	<tr>
		<td>22.</td>
		<td>Methaqualone</td>
		<td>Illicit, Withdrawn</td>
		<td>For the treatment of insomnia, and as a sedative and muscle relaxant.</td>
	</tr></table>
<div class="footer"> Copyright &copy : IIT Kanpur
</div>	
</div>
</body>
</html>